CannDetect Founding
The company was founded by an American Chemist with a MS and a PhD education in Chemistry from the University of Nebraska Lincoln as well as a BA in Chemistry from Mercer University. He is a member of the American Chemical Society and his undergraduate & graduate degrees are certified by the ACS. The founder has two Doctoral Fellowships from the National Institutes of Health and one from UNL. He has an established career in the fields of Chemistry and Information Technology. He is a Genetics subject matter expert who cloned 3 genes. His graduate research focused on "Cancer & Aging." He invented the synthetic replication of chromosomes end-to-end using Polymerase Chain Reaction technology and Telomeric synthetic DNA oligomers. He also invented the telomeric end length PCR reaction commonly used to identify tumors in children by Oncologists worldwide today. He was the first person to ever crystallize a Telomere Binding Protein. He was involved in setting up NIH funded core facilities for analyzing Biochemical & Genetic data at UNL. Some of the founder's graduate school mentors are the following Nobel Laureates: Thomas Cech, Ignacio Tinoco, Peter Klobutcher, Daniel Nathans, Elizabeth Blackburn, Carol Grieder, David Gelfand, and others involving Telomere cancer research. He was mentored by Dr. Robert Hargrove, Chemical warefare weapons expert and Captain of the US Navy in undergraduate studies. He did a COOP with Audiovox during his undergraduate studies at Mercer University in the industrial chemical product space where he founded the chemical product R&D of the company.
Early in life the founder started out as a gamer, a hacker, and a cracker of computer software & hardware in the late 70s and evolved from there. Later in life the founder shifted gears from the Chemistry fields of expertise and focused on information technology and computing as it applied to chemical manufacturing for Amalie. He was involved in developing communications encryption for the US Military under NSA Black Budget projects in the late 1990s. He later moved on into the telecommunications space where he spent 17 years developing sophisticated network engineering analytics and network surveillance products as part of strategic business for Intermedia Communications, MCI-WorldCom, and Verizon. On 9/11/2001 he analyzed the state of NY Empire-Net network communications impact due to terrorist attack for the FBI. He was awarded a patent in SS7 to VOIP call algorithm tracing in Aug, 2014, and developed NSA PRISM feeds for Call Data Records in the 3.3+ billion record per a day volume in C/C++. He is a cybersecurity expert with 7 patents in the telecom space ranging from identity to cybersecurity.
The founder of the company has returned to the field of Biochemistry for the purpose of combining analog networking skills acquired in the telecom industry with complex neural brain networking as humankind emerges toward the Singularity convergence with human made machinery. The emergence of the Singularity in conjunction with the end to prohibition for marijuana and the medicinal applications has created a niche opportunity to create technology related to the next generation neural networking detection of cannabinoid human impairment. The business opportunity combined with the 74% increase year-over-year revenues in the recreation & medical marijuana field along with the issues plaguing law enforcement & the US military with the capacity to detect synthetic cannabinoid impairment in real-time has created a challenge that the founder is interested in from a entrepreneurial perspective.